Effects of erdosteine on bleomycin-induced lung fibrosis in rats

被引:37
|
作者
Boyaci, H
Maral, H
Turan, G
Basyigit, I
Dillioglugil, MÖ
Yildiz, F
Tugay, M
Pala, A
Erçin, C
机构
[1] Kocaeli Univ, Sch Med, Dept Pediat Surg, Kocaeli, Turkey
[2] Kocaeli Univ, Sch Med, Dept Pathol, Kocaeli, Turkey
[3] Kocaeli Univ, Sch Med, Dept Biochem, Kocaeli, Turkey
[4] Kocaeli Univ, Sch Med, Dept Chest Dis, Kocaeli, Turkey
关键词
bleomycin; erdosteine; lung; nitric oxide;
D O I
10.1007/s11010-006-0640-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague-Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin+erdosteine (BLM+ERD), and saline alone (control). The BLM and BLM+ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM+ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM+ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 +/- 0.15, 0.11 +/- 0.02, and 0.087 +/- 0.03 nmol/mg protein in BLM, BLM+ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 +/- 0.06, 0.60 +/- 0.09, and 0.56 +/- 0.1 mu mol/mg protein in BLM, BLM+ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 +/- 12.4, 253.2 +/- 25.2, and 287.9 +/- 34.4 nmol/mg protein) (SOD levels were 1.42 +/- 0.12, 1.75 +/- 0.17, and 1.89 +/- 0.09 U/mg protein) in BLM, BLM+ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [1] Effects of erdosteine on bleomycin-induced lung fibrosis in rats
    Haşim Boyacı
    Hale Maral
    Gupse Turan
    İlknur Başyiğit
    Meltem Ö. Dillioğlugil
    Füsun Yıldız
    Melih Tugay
    Ayşe Pala
    Cengiz Erçin
    Molecular and Cellular Biochemistry, 2006, 281 : 129 - 137
  • [2] Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats
    Yildirim, Z
    Turkoz, Y
    Kotuk, M
    Armutcu, F
    Gurel, A
    Iraz, M
    Ozen, S
    Aydogdu, I
    Akyol, O
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 11 (02): : 156 - 165
  • [3] Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats
    Sogut, S
    Ozyurt, H
    Armutcu, F
    Kart, L
    Iraz, M
    Akyol, O
    Ozen, S
    Kaplan, S
    Temel, I
    Yildirim, Z
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) : 213 - 220
  • [4] in pulmonary fibrosis induced by bleomycin in rats on the effects of inflammation and fibrosis of erdosteine
    Karapolat, Sami
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2009, 57 (02): : 244 - 245
  • [5] Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin
    Erden, Ersin Sukru
    Kirkil, Gamze
    Deveci, Figen
    Ilhan, Nevin
    Cobanoglu, Bengu
    Turgut, Teyfik
    Muz, Mehmet Hamdi
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2008, 56 (02): : 127 - 138
  • [6] Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats:: erdosteine and N-acetylcysteine
    Yidirim, Z
    Kotuk, M
    Iraz, M
    Kuku, I
    Ulu, R
    Armutcu, F
    Ozen, S
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (05) : 367 - 373
  • [7] Attenuation of bleomycin-induced lung fibrosis in rats by mesna
    El-Medany, A
    Hagar, HH
    Moursi, M
    At Muhammed, R
    El-Rakhawy, FI
    El-Medany, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 509 (01) : 61 - 70
  • [8] Preventive and early therapeutic effects of β-Glucan on the bleomycin-induced lung fibrosis in rats
    Iraz, M.
    Bilgic, S.
    Samdanci, E.
    Ozerol, E.
    Tanbek, K.
    Iraz, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (08) : 1505 - 1516
  • [9] EFFECTS OF TAURINE ON BLEOMYCIN-INDUCED LUNG FIBROSIS IN HAMSTERS
    WANG, QJ
    GIRI, SN
    HYDE, DM
    NAKASHIMA, JM
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1989, 190 (04): : 330 - 338
  • [10] Effects of antifibrogenetic agents on bleomycin-induced lung fibrosis
    Cozzi, F
    Oliviero, F
    Sfriso, R
    Baritussio, A
    Gambaro, G
    Calabrese, F
    Ostuni, F
    Todesco, S
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 342 - 342